PetIQ’s Acquisition of Capstar Elanco Animal Health


Baker Botts LLP advised PetIQ on the deal.

PetIQ announced its acquisition of Capstar, an oral tablet that kills fleas in dogs and cats, from Elanco Animal Health Incorporated in an all-cash $95 million deal following U.S. Federal Trade Commission approval of Elanco’s global acquisition of Bayer Animal Health.

PetIQ, Inc. manufactures and distributes health and wellness products for dogs and cats. The Company offers pet prescription medications, over-the-counter flea and tick preventives, health and wellness supplements, and dog and cat treats. PetIQ operates in the United States.

The Baker Botts team was led by Steve Weissman (Picture), assisted by Jana Seidl.

Involved fees earner: Jana Seidl – Baker Botts; Stephen Weissman – Baker Botts;

Law Firms: Baker Botts;

Clients: PetIQ Inc;

Author: Ambrogio Visconti